Department of Biochemistry, Bose Institute, Kolkata, West Bengal, India.
BMB Rep. 2010 Jul;43(7):468-73. doi: 10.5483/bmbrep.2010.43.7.468.
Previously, various inhibitors of cell wall synthesis induced the drp35 gene of Staphylococcus aureus efficiently. To determine whether drp35 could be exploited in antistaphylococcal drug discovery, we cloned the promoter of drp35 (P(d)) and developed different biological assay systems using an engineered S. aureus strain that harbors a chromosomally-integrated P(d) - lacZ transcriptional fusion. An agarose-based assay showed that P(d) is induced not only by the cell wall-affecting antibiotics but also by rifampicin and ciprofloxacin. In contrast, a liquid medium-based assay revealed the induction of P(d) specifically by the cell wall-affecting antibiotics. Induction of P(d) by sublethal concentrations of cell wall-affecting antibiotics was even assessable in a microtiter plate assay format, indicating that this assay system could be potentially used for high-throughput screening of new cell wall-inhibiting compounds.
先前,各种细胞壁合成抑制剂有效地诱导了金黄色葡萄球菌的 drp35 基因。为了确定 drp35 是否可以用于抗葡萄球菌药物的发现,我们克隆了 drp35 的启动子(P(d)),并使用携带染色体整合的 P(d) - lacZ 转录融合的工程化金黄色葡萄球菌菌株开发了不同的生物测定系统。基于琼脂糖的测定表明,P(d)不仅被细胞壁影响抗生素诱导,而且被利福平诱导和环丙沙星。相比之下,基于液体培养基的测定显示 P(d) 特异性地被细胞壁影响抗生素诱导。在微量滴定板测定格式中甚至可以评估亚致死浓度的细胞壁影响抗生素对 P(d) 的诱导,表明该测定系统可用于新的细胞壁抑制化合物的高通量筛选。